Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity. Journal of Carcinogenesis, [S. l.], v. 24, n. 8s, p. 343–351, 2025. DOI: 10.64149/J.Carcinog.24.8s.343-351. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1260. Acesso em: 7 dec. 2025.